Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • 3,00% Takeda Pharmaceutikal Co. Ltd. 18/30 auf Festzins News

    Geld Brief
    96,03 96,88 -0,18%
    Kurse in % | 17:03:30 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2RUPU
    ISIN: XS1843449395
    Typ: Anleihe

    3,00% Takeda Pharmaceutikal Co. Ltd. 18/30 auf Festzins News

    04.02.21 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated ...
    29.10.20 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated ...
    24.08.20 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Takeda to Divest its Japan Consumer Health Care Business Unit to Blackstone for JPY 242.0 Billion
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Disposal Takeda Pharmaceutical Company Limited: Takeda to Divest its Japan Consumer Health Care ...
    31.07.20 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated ...
    04.02.20 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated ...
    31.10.19 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Annual Results Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated ...
    06.09.19 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Takeda Issues US Recall of NATPARA(R) (parathyroid hormone) for Injection Due to the Potential for Rubber Particulate
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Miscellaneous Takeda Pharmaceutical Company Limited: Takeda Issues US Recall of NATPARA(R) ...
    31.07.19 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Quarter Results/Change in Forecast Takeda Pharmaceutical Company Limited: Takeda Reports Strong First ...
    25.04.19 - DGAP
    Ad hoc: Takeda Pharmaceutical Company Limited: Revised Forecast of Consolidated Financials for FY2018 (IFRS)
    DGAP-​Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Annual Results Takeda Pharmaceutical Company Limited: Revised Forecast of Consolidated Financials for ...

    Newssuche

    Videos

    newspaper
    14:00 Uhr -11,78%
    Technical Trading: Gold Produzentenkäufe
    Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »